Courtagen Life Sciences Blog

Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent

Posted by Courtagen Staff on Feb 24, 2017 11:45:04 AM

We are excited to announce that we received a Notice of Allowance from the United States Patent and Trademark Office for a patent that uses a personalized medicine approach to match genetic markers for chronic pain with therapeutic drugs, including the cannabis-derived compound cannabidiol.

Read More

Topics: Genetic Testing, Cannabis, Chronic Pain

Diagnosing Hyperparathyroidism with Genetic Testing

Posted by Meghan Wayne, MS, LGC on Feb 14, 2017 11:39:03 AM

Primary hyperparathyroidism is a disorder of the parathyroid glands caused by overproduction of parathyroid hormone (PTH). This overproduction leads to high blood calcium and causes symptoms such as muscle weakness, fatigue, depression, bone and joint pain, nausea, vomiting, constipation, confusion or impaired thinking and memory, kidney stones, frequent urination, and osteoporosis.

Read More

Topics: Genetics, endocrinology

New Spotlight Panels are Here!

Posted by Courtagen Staff on Feb 7, 2017 12:20:24 PM

We are happy to announce that we have added 17 new gene panels to our Spotlight line of tests. These new tests will expand our menu by 65%, offering new testing options in neurology, endocrinology, epilepsy, developmental delay, mitochondrial disease, and other disease areas.

Read More

Topics: Epilepsy, Genetic Testing, Genetics, endocrinology

Genetic Testing Helps Patient Beat 10 Year Battle with Seizures

Posted by Courtagen Staff on Jan 13, 2017 2:42:20 PM


Read More

Topics: Epilepsy, Genetic Testing, Success Story

Pathogenic, Benign, or Uncertain: Evaluating Genetic Variants

Posted by Cheryl Scacheri, MS, LGC on Jan 5, 2017 2:03:00 PM
Read More

Topics: Genetic Testing, Genetics

Autism, Intellectual Disability, or Both?

Posted by Jane Schuette, MS, CGC on Dec 15, 2016 11:43:00 AM

Autism spectrum disorder (ASD) and intellectual disability (ID) have long been considered clinically distinct conditions, but a closer look suggests the two may be linked and share an underlying genetic cause.

Read More

The Power of Parents: How Parent Samples Improve Genetic Testing Results

Posted by Cheryl Scacheri, MS, LGC on Dec 8, 2016 10:45:00 AM

At Courtagen, we offer DNA testing that uses next generation sequencing to diagnose neurological, mitochondrial, and other disorders. Because the brain and mitochondria are so complex, many of our panels have a thousand genes or more.

Read More

Topics: Seizure Disorders, Mitochondrial Disorders, Genetic Testing, Developmental Delay

ALG13: X-Linked Gene Causes Severe Neurological Disease in Females

Posted by Stacey Wong, MS, LCGC on Nov 22, 2016 9:04:00 AM

After performing diagnostic testing on several thousand patients with seizure disorders, Courtagen's Clinical Team has described a variant in the ALG13 gene that directly causes infantile spasms, intellectual disability, and severe neurologic disease.

Read More

Topics: Epilepsy, Seizure Disorders, Genetic Testing

Is Cannabis a Reasonable Option for Treating Epilepsy?

Posted by Courtagen Staff on Nov 10, 2016 2:06:00 PM

Earlier this week, voters in four states (Arkansas, Florida, Montana, and North Dakota) approved legislation that made medicinal marijuana legal in their respective states. Now more than half the states have approved medical marijuana in some form. It’s fitting that this landmark was reached in the month of November, which happens to be Epilepsy Awareness month.

Read More

Topics: Epilepsy, Genetics, Cannabis

How Courtagen's Genetic Tests Differ from 23andMe

Posted by Cheryl Scacheri, MS, LGC on Oct 26, 2016 3:46:02 PM
Read More

Topics: Genetic Testing, Genetics